Porsbjerg, Celeste M; Menzies-Gow, Andrew N; Tran, Trung N; Murray, Ruth B; Unni, Bindhu; Audrey Ang, Shi Ling; Alacqua, Marianna; Al-Ahmad, Mona; Al-Lehebi, Riyad; Altraja, Alan; Belevskiy, Andrey S; Björnsdóttir, Unnur Steina; Bourdin, Arnaud; Busby, John; Canonica, G Walter; Christoff, George C; Cosio, Borja G; Costello, Richard W; FitzGerald, J Mark; Fonseca, João A; Hansen, Susanne; Heaney, Liam G; Heffler, Enrico; Hew, Mark; Iwanaga, Takashi; Jackson, Daniel J; Kocks, Janwillem W H; Kallieri, Maria; Bruce Ko, Hsin-Kuo; Koh, Mariko Siyue; Larenas-Linnemann, Désirée; Lehtimäki, Lauri A; Loukides, Stelios; Lugogo, Njira; Maspero, Jorge; Papaioannou, Andriana I; Perez-de-Llano, Luis; Pitrez, Paulo Márcio; Popov, Todor A; Rasmussen, Linda M; Rhee, Chin Kook; Sadatsafavi, Mohsen; Schmid, Johannes; Siddiqui, Salman; Taillé, Camille; Taube, Christian; Torres-Duque, Carlos A; Ulrik, Charlotte; Upham, John W; Wang, Eileen; Wechsler, Michael E; Bulathsinhala, Lakmini; Carter, Victoria; Chaudhry, Isha; Eleangovan, Neva; Hosseini, Naeimeh; Rowlands, Mari-Anne; Price, David B; van Boven, Job F M
(2022-05)
BACKGROUND: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. OBJECTIVE: To compare global differences in ease of access to biologics. ...
(2022-05)BACKGROUND: Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. OBJECTIVE: To compare global differences in ease of access to biologics. ...